To the Editor,

I was delighted to read D'Abreu and Friedman's[@b01] review, which addressed the question of whether tardive dyskinesia (TD) may be due to non-dopamine receptor-blocking medications. Their answer in the negative is a valuable contribution to the field. However, I fear that they have missed the opportunity to address an important issue that is typically neglected, especially in studies of TD in the psychiatric literature. While the authors mention references that refer to "spontaneous dyskinesia" affecting the lower face, particularly in elderly people, they do not discuss the likelihood that these patients probably have cranial dystonia. Late-onset primary dystonia, which includes cranial segmental dystonia, blepharospasm, and other facial dystonias that might phenotypically resemble TD, has a prevalence of 100--400 per million.[@b02] These forms of dystonia are probably under-recognized and underdiagnosed, and may potentially be exacerbated by the use of medications such as antidepressants, or erroneously attributed to the coincidental use of such a medication.
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